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The Binding Site for TRAF2 and TRAF3
but Not for TRAF6 Is Essential
for CD40-Mediated Immunoglobulin Class Switching
region (aa 222–229) (Hanissian and Geha, 1997), a TRAF6
binding KxxPxE motif (aa 231–236) (Pullen et al., 1998),
and a PxQxT motif (aa 250–254), that binds TRAF2 and
TRAF3 (Cheng et al., 1995; Lee et al., 1999; Pullen et
al., 1998; Sutherland et al., 1999). TRAF2 and TRAF3,
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CD40 ligation in B cells causes activation of the MAP
kinases JNK and p38 (Li et al., 1996) and of the transcrip-
tion factor NFB (Berberich et al., 1994; Iciek et al.,Summary
1997). Studies in B cell lines suggest that TRAF proteins
play an important role in CD40 signaling. TRAF2 lackingTo define the role of TRAF proteins in CD40-dependent
isotype switching in B cells, we introduced wild-type an amino-terminal RING finger domain is a dominant-
negative inhibitor of CD40 activation of NFB (Rothe et(WT) and mutant CD40 transgenes that lacked the bind-
ing motifs for TRAF6 (CD40TRAF6), TRAF2 and TRAF3 al., 1995). TRAF2 and TRAF6 synergize in NFB activa-
tion (Lee et al., 1999; Tsukamoto et al., 1999). TRAF6,(CD40TRAF2/3), or both (CD40TRAFs) into B cells
of CD40/ mice. The in vivo isotype switch defect in TRAF2, and TRAF3 all have been reported to be involved
in JNK and p38 activation by CD40 (Grammer et al.,CD40/ mice was fully corrected by WT and CD40
TRAF6, partially by CD40TRAF2/3, and not at all 1998; Leo et al., 1999a; Reinhard et al., 1997; Song et
al., 1997; Sutherland et al., 1999).by CD40TRAFs transgenes. CD40-mediated isotype
switching, proliferation, and activation of p38, JNK, The role of TRAF proteins in CD40-mediated isotype
switching is not well defined. Both TRAF6 and TRAF2/3and NFB in B cells were normal in WT and CD40TRAF6
mice, severely impaired in CD40TRAF2/3, and absent binding sites are important for NFB-dependent CD40-
mediated activation of the C1 and C promoters (Leoin CD40TRAFs mice. These results suggest that bind-
ing to TRAF2 and/or TRAF3 but not TRAF6 is essential et al., 1999b). Although isotype switching in B cells of
TRAF3/ and TRAF6/ mice is defective, these micefor CD40 isotype switching and activation in B cells.
die perinatally and have generalized defects in T and
B cell activation, making the findings hard to interpretIntroduction
(Lomaga et al., 1999; Naito et al., 1999; Xu et al., 1996).
TRAF2/ mice also die perinatally, but TRAF2/Immunoglobulin class switching in the course of the
response to T-dependent antigens involves deletional TNFR1/ mice are viable and have impaired T helper-
dependent antibody responses (Nguyen et al., 1999; Yehswitch recombination and requires two signals (Bacha-
rier et al., 1998). One signal is delivered by cytokines et al., 1997). B cells from TRAF5/ mice switch to IgG
in response to TD antigens, although affinity maturationwhich target specific C heavy chain (CH) locus for switch
recombination by causing their transcription. The other is impaired and their B cells show defective production
of IgG in response to stimulation with anti-CD40IL-4signal is delivered by ligation of the B cell surface antigen
CD40. (Nakano et al., 1999). Isotype switching is intact in
TRAF1/ mice (Tsitsikov et al., 2001).CD40 is a member of the TNFR family of surface mole-
cules and is expressed on all B cells (Banchereau et al., To examine the role of TRAF proteins in CD40 isotype
switching and to circumvent the potential deleterious1994). Its ligand (CD40L) is expressed transiently on
activated T cells. The critical role of CD40-CD40L inter- effects of the disruption of TRAF genes on immune cells,
we examined the ability of transgenes coding for CD40actions in isotype switching is illustrated by several ob-
servations: anti-CD40 mAb bypasses the requirement mutants that lack one or both TRAF binding sites to
reconstitute isotype switching in CD40/ B cells.for T cells in IL-4-driven IgE isotype switching in vitro
(Jabara et al., 1990); mutations in the CD40L underlie the
isotype switch defect in patients with X-linked HyperIgM Results
syndrome (Fuleihan et al., 1993); and mice deficient in
CD40 or CD40L fail to undergo isotype switching in Reconstitution of CD40/ Mice with CD40 Transgenes
response to T-dependent (TD) antigens (Castigli et al., WT and mutant murine CD40 constructs were generated
1994; Kawabe et al., 1994; Xu et al., 1994). as illustrated in Figure 1A. CD40 231–246, designated
The intracellular domain of human CD40 has a binding CD40TRAF6, lacks the sequence 234RQDPQE239, which
site for Jak3 in its proline-rich Box 1 membrane proximal shows homology to the TRAF6 binding motif KxxPxE in
human CD40 (Pullen et al., 1998). CD40 T255A, designated
CD40TRAF2/3, carries a T255A point mutation in the3 Correspondence: raif.geha@tch.harvard.edu
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Figure 1. Characterization of the CD40 Mutants
(A) Schematic representation of WT CD40 and mutant transgenes used: WT (CD40WT), CD40TRAF6 (CD40TR6), CD40TRAF2/3 (CD40TR2/
3), and CD40TRAFs (CD40TRs).
(B) Association of TRAF proteins with CD40 mutants. Left panel: expression of TRAF proteins in M12 B cells; right panel: GST-mCD40 pull-
down assay with M12 B cell lysates. Bound proteins were probed for the presence of TRAF proteins.
(C) Representative FACS analysis of CD40 surface expression in PBMCs, bone marrow, and spleen of 8- to 12-week-old transgenic mice
after staining with anti-B220-FITC and anti-CD40-PE.
251PxQxT255 sequence, which corresponds to the T254A role for TRAF6 binding in CD40 signaling. Therefore,
constructs containing WT and all three mutant CD40mutation in human CD40 that abolishes TRAF2 and
TRAF3 binding (Pullen et al., 1998). CD40231–246/ cDNAs were used to create transgenic mice which were
bred on the CD40/ background. Lines that expressedT255A, designated CD40TRAFs, carries both muta-
tions present in TRAF6 and TRAF2/3. CD40 only on B220 cells and in amounts comparable
to those expressed in CD40/ mice were selected forTo determine if the CD40 mutants lacked the expected
associations with TRAF molecules, GST-WT CD40 and study. For each of the constructs, at least two transgenic
lines derived from separate founders were studied andmutant fusion proteins were examined for their capacity
to bind TRAF proteins in lysates of the murine B cell line similar results were obtained, with the exception of
CD40TRAF6 where one out of four lines studied gaveM12, that expresses TRAF2, TRAF3, and TRAF6 (Figure
1B, left panel). GST-CD40WT and GST-CD40TRAF6 as- aberrant results and was excluded from analysis.
FACS analysis of CD40 expression on peripheral bloodsociated with TRAF2 and TRAF3. In contrast, GST-
CD40TRAF2/3 and GST-CD40TRAFs did not. GST- lymphocytes from representative lines of reconstituted
CD40/ mice is shown in Figure 1C. Of the two linesCD40WT and all three mutant fusion proteins showed
no detectable association with TRAF6 (Figure 1B, right reconstituted with WT CD40 studied, one line (CD40WT#1)
expressed CD40 on all B cells and was used as a controlpanel). Furthermore, GST-CD40WT did not bind TRAF6
from lysates of HEK 293 cells that overexpressed mTRAF6 for CD40TRAF6 mice which expressed CD40 on all B
cells. The second line (CD40WT#2) expressed CD40 on(data not shown).
mCD40 and mTRAF6 interact in the yeast two-hybrid 50% of the B cells. It was used as a control for
CD40TRAF2/3 and CD40TRAFs mice which ex-assay (Ishida et al., 1996). Our failure to detect their
interaction in a pull-down assay may be due to the fact pressed CD40 on 45%–50% and 30%–35% of their B
cells, respectively. The mean fluorescence intensity ofthat it is weak or unstable, and does not rule out a
Role of TRAF Binding to CD40 in Isotype Switching
267
CD40 expression on B cells from all mouse lines studied to KLH, poor IgG2a and IgG2b responses, and no detect-
was comparable to that of B cells from CD40/ mice. able IgG1 and IgE responses (Figure 3A). Mice reconsti-
CD40 expression has remained stable for more than tuted with CD40WT mounted a normal antibody re-
three generations in each of the lines analyzed. sponse comparable to that of CD40/ mice in all Ig
classes examined, regardless of whether CD40 was ex-
Phenotypic Analysis of Lymphoid Organs pressed on all B cells (CD40WT#1) or on 50% of the
Like CD40/ mice (Castigli et al., 1994; Kawabe et al., B cells (CD40WT#2). CD40TRAF6 normalized the anti-
1994), bone marrow (BM) from all transgenic mouse body response to KLH. CD40TRAF2/3 reconstituted
lines had normal cellularity and normal percentage and IgG2b and IgE responses to normal, but IgG1 and IgG2a
expression profile of IgM and B220 cells (data not responses were poorly restored (Figure 3A). CD40
shown). This suggests that introduction of the trans- TRAFs reconstituted the IgG2b response but not the
genes did not interfere with B cell development. In all IgG1, IgG2a, and IgE responses. All three CD40 mutant
transgenic lines, the fraction of B220 BM cells that transgenic mice made normal IgM and IgG3 antibody
expressed CD40 matched that in peripheral blood (Fig- responses.
ure 1C). In normal BM, CD40 is highly expressed on Spleens from KLH-immunized CD40/ mice revealed
B220high cells but is absent or poorly expressed on the presence of multiple germinal centers (Figure 3B).
B220low cells. In contrast, in all transgenic lines, both These were absent from spleens of nonimmunized mice
B220low and B220high BM cells expressed high levels of (data not shown) and from spleens of immunized
CD40. This likely reflects the fact that the EVH promoter, CD40/ mice, as previously reported (Castigli et al.,
used to drive transgene expression, is active at earlier 1994; Kawabe et al., 1994). Mice reconstituted with
stages of B cell development than the endogenous CD40 CD40WT had prominent germinal centers in their
gene promoter, which is poorly active in pre-B cells and spleens with numbers similar to those found in CD40/
immature B cells (Castigli et al., 1996). mice, regardless of whether CD40 was expressed on all
Spleens were normal in size and cellularity in all trans- B cells (CD40WT#1) or on only 50% of the B cells
genic mice. We previously reported that the number and (CD40WT#2). Reconstitution with CD40TRAF6 fully
phenotype of B cells in the spleen of CD40/ mice restored germinal center formation to normal. Germinal
are normal as assessed by staining for B220 and IgM center formation was partially restored in CD40TRAF2/3
(Castigli et al., 1994). The numbers of CD3 and B220 mice. These mice had smaller and less developed germi-
cells and the expression of IgM on B220 cells in the nal centers than control CD40WT#2 mice. Germinal cen-
spleens of all transgenic mice were similar to those of ters were absent from spleens of CD40TRAFs mice.
CD40/ mice (data not shown). In all lines, the expres-
sion of CD40 on B220 cells in spleen and peripheral CD40-Mediated Isotype Switching In Vitro
blood was comparable (Figure 1C). The thymus was CD40 ligation in the presence of IL-4 causes isotype
normal in size, architecture, and numbers of CD4, CD8, switching to IgE and IgG1 (Hasbold et al., 1998; Jabara
and CD3 positive cells in all transgenic lines (data not
et al., 1990). Since CD40TRAF2/3 and CD40TRAFs
shown).
mice expressed CD40 on only a fraction of their B cells,
CD40 B cells were purified from spleens and wereSerum Immunoglobulin Levels
stimulated with hamster IgM anti-mouse CD40 and IL-4.CD40/ mice have decreased serum IgG1 and IgG2a,
The purification procedure by itself did not activate theundetectable IgE, and normal or modestly decreased
B cells because unstimulated purified CD40 B cells didIgM, IgG2b, IgG3, and IgA (Castigli et al., 1994; Kawabe
not proliferate nor secrete IgE or IgG1 (see legend ofet al., 1994). Introduction of the CD40WT transgene in
Figure 4). B cells from mice reconstituted with CD40WTthe CD40/ background resulted in normalization of
or with CD40TRAF6 secreted comparable amounts ofserum IgG1, IgG2a, and IgE levels, both in the line where
IgE and IgG1 in response to anti-CD40IL-4 as B cellsCD40 was expressed on all B cells, CD40WT#1, and in
from CD40/ mice (Figure 4A). In contrast, B cells fromthe line where CD40 was expressed on 50% of the B
CD40TRAF2/3 and CD40TRAFs mice secreted verycells, CD40WT#2 (Figure 2). Reconstitution with CD40
little or no detectable amounts of IgE and IgG1 followingTRAF6 resulted in normalization of serum IgG1, IgG2a,
stimulation with anti-CD40IL-4 (Figure 4A). This wasand IgE to levels not significantly different from those
not due to a general impairment in the ability of theseof CD40WT#1 controls. Reconstitution with CD40
B cells to undergo isotype switching or to respond toTRAF2/3 partially restored serum IgG1 and IgE levels,
IL-4, because they secreted normal amounts of IgE andbut IgG2a levels were poorly restored. Serum IgG1,
IgG1 in response to LPSIL-4 (Figure 4A).IgG2a, and IgA were significantly lower in CD40TRAF2/
CD40 ligation synergizes with IL-4 in activating a num-3 mice than in CD40WT#2 controls. Reconstitution with
ber of molecular events that result in class switch recom-CD40TRAFs completely failed to restore serum IgG1,
bination (CSR) to IgE and IgG1. These include ex-IgG2a, and IgE levels. Serum IgG1, IgG2a, IgA, and IgE
pression of C and C1 germline transcripts (GLTs),were significantly lower in CD40TRAFs mice than in
expression of the gene for activation-induced deami-CD40WT#2 controls. Serum levels of IgG2b and IgG3
nase (AID), followed by S→S and S→S1 deletionalwere in the normal range in all reconstituted mice.
switch recombination and expression of mature I-C
and I-C1 transcripts (Manis et al., 2002). The abilityAntibody Response and Germinal Center Formation
of CD40 mutants to activate these events was examinedto the TD Antigen KLH
in B cells from transgenic mice. CD40 ligation and IL-4As previously reported (Kawabe et al., 1994), CD40/
mice made normal IgM and IgG3 antibody responses each induced expression of C1 GLT and synergized in
Immunity
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Figure 2. Serum Immunoglobulins in
CD40/ Mice Reconstituted with CD40
Transgenes
Serum immunoglobulin levels from nonimmu-
nized 12-week-old CD40/ mice reconsti-
tuted with CD40 transgenes, CD40/
littermates (/), and CD40/ mice (/).
Mann Whitney test was used to compare
CD40TR6 to CD40WT#1 and CD40TR2/3
and CD40TRs to CD40WT#2 mice. Signifi-
cantly different values are indicated: * p 
0.05, ** p  0.01, and *** p  0.001.
inducing C1 GLT in normal CD40/ B cells (Figure 5A). CD40 ligation and IL-4 each induced weak expression
of AID, but synergized to induce strong AID gene expres-CD40 ligation synergized with IL-4 in inducing C GLT
in normal B cells, but neither stimulus induced C GLT sion in B cells from CD40/ mice. B cells from CD40WT
and CD40TRAF6 mice expressed AID comparably toby itself at the time point examined (4 days poststimula-
tion). B cells from CD40WT and CD40TRAF6 mice ex- normal CD40/ B cells (Figure 5A). CD40 ligation in-
duced weak expression of AID in B cells frompressed C1 and C GLT comparably to normal B cells.
In contrast, CD40 ligation failed to induce C1 GLT and CD40TRAF2/3 and CD40TRAFs mice and poorly
upregulated AID expression induced by IL-4 in these Bto upregulate IL-4-induced C1 GLT in B cells from
CD40TRAF2/3 and CD40TRAFs mice. CD40 ligation cells. All B cells expressed comparable amounts of AID
following stimulation with IL-4 and LPSIL-4.and IL-4 induced weak expression of C GLT in B cells
from CD40TRAF2/3 mice and no detectable C GLT CD40 ligation synergized with IL-4 in causing S→S1
and S→S deletional switch recombination (Figure 5B)expression in B cells from CD40TRAFs mice. B cells
from all mice expressed comparable amounts of C1 and in inducing mature I-C1 and I-C transcripts
in B cells from CD40/ mice (Figure 5C), but neitherGLT in response to IL-4 and of C1 and C GLT in
response to LPSIL-4. stimulus induced these events by itself (data not shown).
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Figure 3. Antibody Response and Germinal Center Formation in Response to KLH
(A) IgM, IgG subclasses, and IgE antigen-specific antibody responses to KLH following immunization with the TD antigen in CD40/ mice
reconstituted with CD40 transgenes, CD40/ littermates (/), and CD40/ mice (/). Statistical analysis was performed as in Figure 3.
(B) Spleen sections (	40) from mice immunized with KLH examined for PNA binding by immunohistochemistry.
Deletional switch recombination and expression of ma- CD40-Mediated B Cell Proliferation
CD40 ligation causes B cell proliferation (Banchereauture transcripts in response to anti-CD40IL-4 were nor-
mal in B cells from CD40WT and CD40TRAF6 mice. In et al., 1994). B cells from mice reconstituted with
CD40WT or with CD40TRAF6 proliferated in responsecontrast, they were markedly diminished in B cells from
CD40TRAF2/3 mice and undetectable in B cells from to CD40 crosslinking to an extent comparable to that
of B cells from CD40/ mice. In contrast, CD40 B cellsCD40TRAFs mice. All B cells underwent S→S1 and
S→S deletional switch recombination and expressed from CD40TRAF2/3 and CD40TRAFs mice prolifer-
ated very poorly to stimulation with anti-CD40-IgM (Fig-mature I-C1 and I-C in response to LPSIL-4.
Immunity
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upregulation of these markers was preserved in CD40
B cells from CD40TRAF2/3 mice. In contrast, it was
severely diminished in CD40 B cells from CD40TRAFs
mice. CD40 B cells from all transgenic lines upregu-
lated CD23, CD54, and CD86 expression normally in
response to LPS (Figure 6).
CD40 Activation of NFB in B Cells
CD40 ligation in B cells causes the nuclear translocation
and activation of NFB (Banchereau et al., 1994). Elec-
tromobility shift assay (EMSA) was used to assess the
translocation of NFB following CD40 ligation in purified
CD40 B cells. Figure 7A shows that addition of nuclear
extracts from unstimulated CD40/ B cells to a radiola-
beled oligonucleotide encoding an NFB consensus se-
quence derived from the HIV1 gene gives rise to a re-
tarded complex. This complex was inhibited by an
excess of cold self-competitor but not of irrelevant AP-1
binding consensus sequence oligonucleotide (data not
shown). In three experiments, CD40 ligation on B cells
from CD40/ mice resulted in upregulation of the inten-
sity of the specific nuclear complex (1.9 
 0.4-fold).
CD40-mediated nuclear translocation of NFB in B cells
from CD40WT mice (2.1 
 0.1-fold) and CD40TRAF6
mice (2.1 
 0.9-fold) was comparable to that in B cells
of CD40/ mice. In contrast, it was impaired in B cells
from CD40TRAF2/3 (0.9 
 0.05-fold, p  0.05 com-
pared to CD40WT mice) and CD40TRAFs mice (0.9 

0.1-fold, p 0.05) (Figure 7A). The latter had consistently
increased baseline nuclear NFB content.
CD40 ligation in B cells causes NFB-dependent
upregulation of bcl-xL and A20 gene expression (Dad-
gostar et al., 2002). Expression of both genes was
normally upregulated in B cells of CD40WT and
CD40TRAF6 mice. CD40 ligation upregulated bcl-xL
and A20 expression in B cells from CD40TRAF2/3 mice
but not in B cells from CD40TRAFs mice (Figure 7C).
The latter had elevated baseline levels of bcl-xL and A20
mRNA, which correlated with their increased baseline
Figure 4. Immunoglobulin Synthesis and B Cell Proliferation In Vitro nuclear NFB content but were lower than the levels
(A) Net IgG1 and IgE synthesis by CD40 B cells. IgG1 and IgE in observed in CD40-stimulated control B cells from
supernatants of unstimulated cells were 4 and 7 ng/ml, respec- CD40WT#2 mice.
tively, and were subtracted from values of stimulated cultures. Re-
sults shown are the mean of three experiments.
(B) Proliferation of CD40 B cells. Results are derived from three CD40 Activation of MAP Kinases in B Cells
experiments and expressed as percentage of the proliferation of B
CD40 ligation in resting mouse B cells results in thecells from CD40/ mice (mean
 SD cpm for anti-CD40 27,279

phosphorylation and activation of the MAP kinases p3815,034 and for LPS  74,257 
 16,652). B cells cultured in media
and JNK but not Erk (Aicher et al., 1999 and our unpub-alone incorporated 1100 cpm.
lished data). CD40-mediated phosphorylation of p38
and JNK in CD40 B cells from CD40WT and
CD40TRAF6 mice was comparable to that in B cellsure 4B). This was not due to a general impairment in B
cell proliferation, because all B cells proliferated nor- of CD40/ mice. In contrast, it was not detectable in
B cells from CD40TRAF2/3 and CD40TRAFs micemally in response to LPS.
(Figure 7B).
CD40 ligation causes p38-dependent downregulationCD40-Mediated Upregulation of CD23, CD54,
and CD86 Expression on B Cells of expression of a number of genes that include diacyl-
glycerol kinase  (DAG kinase ) in normal B cells (Dad-CD40 ligation upregulates the expression of a number
of surface markers on B cells, including CD23, CD54, gostar et al., 2002). Expression of DAG kinase  was
normally downregulated in B cells of CD40WT andand CD86 (Banchereau et al., 1994). CD40 B cells from
mice reconstituted with CD40WT or CD40TRAF6 upregu- CD40TRAF6 mice. In contrast, CD40 ligation caused
no detectable downregulation of DAG kinase  expres-lated CD23, CD54, and CD86 expression following
sCD40L stimulation to an extent comparable to that of sion in B cells from CD40TRAF2/3 and CD40TRAFs
mice (Figure 7C).B cells from CD40/ mice (Figure 6). CD40-mediated
Role of TRAF Binding to CD40 in Isotype Switching
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Figure 5. Molecular Events in Isotype Switching
(A) Expression of C and C1 germline and AID transcripts measured by RT-PCR in B cells stimulated for 4 days with IL-4, CD40, CD40IL-4,
and LPSIL-4 as control.
(B) S→S and S→S1 deletional switch recombination measured by DC-PCR at day 6.
(C) Expression I-C and I-C1 mature transcripts by RT-PCR at day 4. Similar results were obtained in three independent experiments.
Discussion vivo and in vitro, as well as CD40 induction of prolifera-
tion, upregulation of CD23, CD54, and CD86 expression,
and activation of NFB, JNK, and p38 (Figures 2–7).Our results suggest that binding to TRAF2 and/or TRAF3
but not TRAF6 is essential for CD40-mediated isotype These results suggest that binding of TRAF6 to CD40
may not be necessary for isotype switching and activa-switching and activation of murine primary B cells.
The transgene reconstitution strategy we have used tion of primary mouse B cells. Moreover, our finding that
mice reconstituted with CD40TRAF2/3, in which theto dissect the role of TRAF proteins in CD40-dependent
isotype switching was validated by the observation that TRAF6 binding site is intact, have severe defects in
CD40-mediated isotype switching, proliferation, and ac-expression of CD40WT transgene in B cells of CD40/
mice completely restored CD40-dependent immuno- tivation of NFB, JNK, and p38 suggests that binding
of TRAF6 to CD40 is not sufficient for CD40 triggeringglobulin class switching and B cell activation (Figures
2–7). In vivo immunoglobulin class switching was nor- of these events.
Our results are consistent with previous findings thatmalized even when CD40WT was expressed on only
50% of the B cells (Figures 2 and 3), suggesting that TRAF6 plays a minimal role in CD40-mediated surface
marker expression and NFB activation in a B cell lineCD40 expression on a fraction of B cells is sufficient to
support normal in vivo Ig class switching. (Jalukar et al., 2000). In contrast, studies in B cell lines
that overexpress dominant-negative (DN) TRAF6 mu-GST-mCD40 bound TRAF2 and TRAF3 in mouse B
cell lysates (Figure 1B). However, despite the presence tants (Jalukar et al., 2000), or trimerized mutant CD40
intracellular domains (Werneburg et al., 2001), have im-of a conserved TRAF6 binding sequence in mCD40 and
the fact that mCD40 and mTRAF6 interact in the yeast plicated TRAF6 in CD40 activation of NFB. However,
overexpression of DN TRAF6 may affect the function oftwo-hybrid assay (Ishida et al., 1996), we were unable
to demonstrate an interaction between GST-mCD40 and other TRAFs, and overexpression of trimerized CD40
intracellular domains may not mimic physiologic signal-TRAF6. Binding of TRAF6 to GST-hCD40 has not been
consistently demonstrated, suggesting that their inter- ing by transmembrane CD40. TRAF6 has also been im-
plicated in CD40 signaling based on studies with B cellsaction is weak and may require a conformational change
in CD40 that could be mimicked by the overexpression from TRAF6/ mice (Lomaga et al., 1999; Naito et al.,
1999). However, TRAF6 deficiency may interfere gener-of trimerized CD40 intracellular domains (Lee et al.,
1999; Leo et al., 1999a; Werneburg et al., 2001). ally with B cell development and function. It remains
possible that TRAF6 plays a role in CD40-mediated BIntroduction into B cells of CD40/ mice of
CD40TRAF6, in which the TRAF6 binding motif is de- cell activation independently of its binding to CD40.
Reconstitution of B cells from CD40/ mice with theleted but which retains the ability to bind TRAF2 and
TRAF3, restored CD40-dependent isotype switching in CD40TRAF2/3 transgene partially restored CD40-depen-
Immunity
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Figure 6. Upregulation of CD23, CD54, and CD86 Expression on B Cells
B cell-enriched splenocytes were left unstimulated (green) or were stimulated overnight with sCD40L from supernatants of CD40L transfected
J558L cells (blue) or LPS (red), then stained with anti-CD40-PE- and FITC-conjugated mAbs to either CD23, CD54, or CD86 and with the
relevant isotype controls. Stimulation with control supernatants of J558L cells transfected with empty plasmid caused no upregulation of
CD23, CD54, or CD86 (data not shown).
dent serum isotype levels, TD antibody responses, and TRAF5/ mice (Nakano et al., 1999; Tsitsikov et al.,
2001). Thus, it is unlikely that loss of binding of TRAF1germinal center formation in vivo (Figures 2 and 3). This
partial restoration is unlikely to be due to the fact that or TRAF5 accounts for the isotype switch defect in
CD40TRAF2/3 mice.only half of the B cells from these mice expressed CD40,
because in vivo isotype class switching and germinal Examination of germline transcription, AID expres-
sion, deletional switch recombination, and mature tran-center formation were fully restored in a line of CD40/
mice reconstituted with CD40WT (CD40WT#2), in which scripts expression demonstrated severely defective
CD40-directed isotype switching to C and C1 in Ba similar percentage of the B cells expressed CD40. In
vitro isotype switching to IgE and IgG1 in response to cells from CD40TRAF2/3 mice (Figure 5). The residual
in vitro switching observed in these cells is consistentCD40/IL-4 stimulation, as well as proliferation to anti-
CD40, were severely impaired in B cells from with the residual in vivo isotype switching observed in
CD40TRAF2/3 mice. Additional signals delivered to theCD40TRAF2/3 mice (Figure 4). These results suggest
an important role for TRAF2/3 binding in CD40-driven B cells in vivo that synergize with residual signaling by
CD40TRAF2/3 to activate class switching may explainisotype switching. TRAF1 and TRAF5 bind to CD40 via
TRAF2 and TRAF3, respectively (Leo et al., 1999a). How- the observation that in vivo isotype switching is less
affected than in vitro CD40 isotype switching inever, CD40-dependent isotype switching to IgG in re-
sponse to TD antigen and CD40 activation of NFB are CD40TRAF2/3 mice. CD40 upregulation of CD23,
CD54, and CD86 expression in B cells ofTRAF2/3 miceintact in TRAF1/ mice and minimally affected in
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Figure 7. CD40 Activation of NFB and MAP
Kinases in Spleen B Cells
(A) EMSA using nuclear extracts from CD40
spleen B cells stimulated with anti-CD40 for
30 min at 37C, and a consensus 32P-labeled
NFB oligonucleotide probe.
(B) Phosphorylation of p38 and JNK. B cells
were stimulated for 5 min with anti-CD40, and
lysates were analyzed for phosphorylation of
p38 and JNK by Western blotting with phos-
pho-specific antibodies. Membranes were
reprobed with kinase-specific antibodies for
loading controls.
(C) A20, bcl-xL, and DAG kinase  mRNA
measured by RT-PCR following 2 hr stimula-
tion with anti-CD40.
was largely preserved (Figure 6). This is consistent with transcription, AID expression, deletional switch recom-
bination, and mature transcripts expression revealed nofindings in B cell lines (Lee et al., 1999) and suggests
that CD40-mediated gene upregulation is not strictly detectable CD40-directed isotype switching in B cells
from CD40TRAFs mice (Figure 5). Furthermore, these Bdependent on TRAF2 and/or TRAF3 binding to CD40.
CD40 activation of NFB, p38, and JNK was impaired cells completely failed to proliferate, upregulate surface
markers, and activate NFB and MAP kinases in re-in B cells from CD40TRAF2/3 mice, although residual
activation of NFB was suggested by preserved CD40 sponse to CD40 ligation (Figures 4–7). The fact that in
vivo and in vitro CD40-directed isotype switching andupregulation of bcl-xL and A20 gene expression (Figure
7). Several effectors that lie in the NFB activation path- activation were partially restored in CD40TRAF2/3
mice but not at all in TRAFs mice suggests that TRAF6way have been shown to play an important role in CD40-
mediated isotype switching and proliferation. They in- binding to CD40, although undetectable in our pull-down
assay, may occur in B cells and synergize with residualclude IKK, IKK/NEMO, p50-, RelA, c-Rel, and p52
(Sha, 1998; Doffinger et al., 2001; Jain et al., 2001; Lee signals delivered via CD40TRAF2/3. However, we can-
not rule out a role for molecules, other than TRAF6,et al., 1999; Richards and Katz, 1997). Furthermore, we
have found that the p38 inhibitor SB203580 and the such as TTRAP, whose association with CD40 may be
disrupted by theTRAF6 deletion, although TTRAP itselfJNK inhibitor SP600125 inhibit IgE and IgG1 secretion
in response to anti-CD40IL-4 but not to LPSIL-4 inhibits CD40 activation of NFB (Pype et al., 2000).
Our results suggest that CD40 binding to TRAF2 and/(H.H.J. et al., unpublished data). Thus, it is likely that
defective CD40 activation of NFB, p38, and JNK in or TRAF3 but not to TRAF6 plays an essential role in
CD40-mediated isotype switching in murine B cells.B cells from CD40TRAF2/3 mice contributes to their
defective CD40-dependent isotype switching and prolif- Since the 32 aa long CD40 intracellular region that sur-
rounds the TRAF2/3 binding site is fully conserved be-eration.
The CD40TRAFs transgene completely failed to cor- tween mouse and man, it is likely that our results are
applicable to human B cells. However, since the affinityrect CD40-dependent isotype switching in vivo and in
vitro (Figures 2–5). Examination of C and C1 germline of hCD40 for TRAF6 may be higher than that of mCD40,
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PBS for 2 hr at 37C and incubated with mAbs to the mouse TRAF3TRAF6 binding may play a more important role in CD40-
(1:500), TRAF6 (1:500) (Santa Cruz Biotechnology), and rabbit anti-mediated isotype switching in human B cells. In addition
mouse TRAF2 (1:250, MBL International) followed by proteinto binding TRAF proteins, the intracellular domain of
G-conjugated to horseradish peroxidase (Bio-Rad). Positive bands
human CD40 binds Jak3 (Hanissian and Geha, 1997; were detected by using ECL reagents (NEN).
Revy et al., 1999). However, studies with B cells from
Jak3-deficient patients have failed to reveal a role for Immunizations
Mice received an intraperitoneal and a subcutaneous injection eachJak3 in CD40-mediated isotype switching, proliferation,
of 200 g of an alum precipitate of KLH (Calbiochem) containingand gene upregulation (Jabara et al., 1998). Furthermore,
pertussis toxin (300 ng/mouse, List Biologicals). A booster dose ofreconstitution of CD40/ mice with a mutant mCD40
30 g of KLH in aqueous solution was injected intraperitoneally on
transgene that lacks the proline-rich aa 222–230 se- day 14. Day 21 mice were sacrificed, their spleens were frozen in
quence that binds to Jak3 resulted in normal CD40- OCT compound (Ames), and blood was collected.
mediated isotype switching and B cell activation (data
not shown). This result, together with our finding that Germinal Center Formation
Frozen spleen tissue sections, 4 m thick, were stained with biotin-deletion of aa 231–246 in TRAF6 does not affect CD40
labeled peanut agglutinin (Vector Laboratories) followed by avidin-function and with the fact that the terminal 11 aa of
biotinylated peroxidase complex (Dako), and developed withmCD40 are absent from hCD40, narrows the region of
3-amino-9-ethylcarbazole (Aldrich).
CD40 important for isotype switching, with the exclusion
of the 6 juxtamembrane aa, to aa 247–278. This 32 aa ELISA Assays
region contains the PxQxT motif essential for TRAF2 Immunoglobulins were assayed by ELISA as described (Spergel et
al., 1998). To measure anti-KLH-specific antibody, plates wereand TRAF3 binding. However, this motif is also present
coated with KLH (10 g/ml) in sodium carbonate buffer (pH 9.0).in TNFR family members which bind TRAF2 and TRAF3,
The wells were blocked with 2% BSA for 2 hr and incubated withyet do not cause isotype switching in B cells, e.g., CD27
diluted sera overnight at 4C. Alkaline phosphatase-conjugated iso-(Nagumo et al., 1998; Yamamoto et al., 1998). This sug-
type-specific antibodies (Pharmigen) were used as revealing anti-
gests that other elements of the aa 247–278 sequence bodies. Anti-KLH-specific standards (Pharmingen) were used to de-
or, alternatively, the transmembrane and/or extracellular termine IgM, IgG1, and IgG3 concentrations. For all other isotypes,
a serum pool of ten normal mice was run in parallel, and the readingsdomain of CD40 may play a critical role in isotype switch-
at 1:25, 1:300, and 1:300 for IgE, IgG2a, and IgG2b, respectively,ing. Current studies are aimed to examine these possibil-
was taken as an arbitrary unit of 1000, to which the serum dilutionsities.
were compared.
Experimental Procedures
RT-PCR
RNA was extracted from cultured splenic B cells using TRIzol (In-Generation of CD40/ Mice with CD40 Transgenes
vitrogen) and was reverse transcribed by Superscript II RT (In-PCR-generated CD40 WT and mutated gene products (Figure 1A)
vitrogen) according to manufacturer’s instructions. PCR primerswere cloned in the pBSVE6BK vector containing an Ig enhancer
used were as described previously for C and C1 germline andand Ig heavy chain (IgVH) promoter (Shaw et al., 1999). Not1-Pvu1
mature transcripts (Muramatsu et al., 2000) and for 2 microglobulinfragments of the CD40 cloned products were injected into pronuclei
(2 m) (Spergel et al., 1998). For AID, A20, Bcl-xl, and DAG kinaseof fertilized oocytes from (C57BL/6/SJL) mice. Founders identified
 transcripts, the following primers were used: AIDF, 5-GGAGACCby PCR and Southern blot analysis of tail DNA were crossed with
GATATGGACAGCCTTCTG-3; AIDR, 5-TCAAAATCCCAACATACCD40/ mice on a C57BL/6/129Sv background. F2 animals that
GAAATGC-3; A20F, 5-ATGGCTGAACAACTTCTTCCTCAGGC-3;were CD40/ transgene positive were further screened for CD40
A20R, 5-GGTCTTCTGAGGATGTTGCTGAGG-3; bcl-xlF, 5-ATGsurface expression by FACS analysis. CD40/ control mice were
TCTCAGAGCAACCGGGAGC-3; bcl-xlR, 5-CCAGCCGCCGTTCTon a mixed C57BL/6/SJL/129Sv background.
CCTGGATCC-3; DAG kinase F, 5-CCAAAGAGAAGGGCCTCAT
CAGC-3; and DAG kinase R, 5-GTGCTGACTTCACAAGGCTFlow Cytometry Analysis
GGG-3. All PCR reactions were performed on various dilutions ofSingle–cell suspensions were stained with fluorescein isothiocya-
cDNA to ensure that the products measured were in the linear range.nate (FITC)- or phycoerythrin (PE)-conjugated antibodies in PBS
Depending on the PCR product being measured, 5 to 30 ng of cDNAcontaining 5% rat serum (Sigma), 0.05% sodium azide, and Fc-
fell within this range.block (Pharmingen), washed, fixed in 2% paraformaldehyde, and
analyzed on a FACSCalibur cytometer (Becton Dickinson). FITC- or
DC-PCRPE-conjugated mAbs used in these studies were: CD3 (145-2C11),
Genomic DNA was isolated from cultured splenic B cells on day 6.CD4 (L3T4), CD8 (53-6.7), B220 (RA3-6B2), anti-CD40 (3/23), anti-
DNA was digested with EcoR1, circularized, and used as templateIgM (R6-60.2), rat IgG2a (R35-95), and hamster IgG (A19-3) (Phar-
for PCR using primers as reported previously for S-S1 and nico-mingen).
tinic acetylcholine receptor  unit (nAChR) (Chu et al., 1992) and for
S-S (Xu and Rothman, 1994). 5 ng of circular DNA was amplifiedCoprecipitation of TRAF Proteins with CD40-GST Fusion Proteins
for S-S1 and nAChR (35 cycles), and 20 ng was amplified forIntracellular regions corresponding to WT and mutant CD40 were
S-S (one round of 34 cycles) .amplified from transgenic constructs by PCR using sense (AAG
GAATTCTGGTCAAGAAACCAAAGGATAATGA) and antisense (AAA
CTCGAGTCAGACCAGGGGCCTCAA) oligonucleotides and sub- Proliferation and IgE Synthesis of B Cells
CD40 B cells were purified from spleen cell suspensions using Dyna-cloned into the EcoRI/XhoI sites of GST expression vector pGEX-
5x-2 (Pharmacia). The fusion proteins were prepared on Glutathione beads M-450 sheep anti-rat IgG (Dynal) coated with rat IgG anti-
mouse CD40 mAb (IC10, R&D Systems). Purified cells were 95%Sepharose beads (Pharmacia) according to the manufacturer’s rec-
ommendations. M12 B cell (1 	 106 cells) lysates in 0.5% Nonidet B220 CD40 by FACS analysis and were suspended in RPMI con-
taining 10% FCS, L-Glutamine, and 50M -mercaptoethanol (com-P-40/150 mM NaCl/10 mM KCl/0.5 mM DTT/0.2 mM/1	 Complete
Protease Inhibitor (CPI) cocktail (Roche) were centrifuged, and the plete medium) and rested 24 hr before stimulation. For Ig synthesis,
CD40 B cells (0.5 	 106 /ml) were cultured in complete mediumsupernatant was incubated with WT or mutant GST-CD40 Sepha-
rose beads. Beads were washed in lysis buffer; bound proteins alone, hamster IgM anti-mouse CD40 (anti-CD40-IgM, 1 g/ml,
HM40-3, Pharmingen)IL-4 (50 ng/ml, R&D systems), or LPS (20were resolved by SDS PAGE gels and transferred onto nitrocellulose
membrane. Membranes were blocked with 2% BSA/0.2% gelatin in g/ml)IL-4 (50 ng/ml). Supernatants were collected after 6 days
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and assayed for IgE and IgG1 by ELISA. For proliferation, CD40 RAG-2 deficient blastocyst complementation. Proc. Natl. Acad. Sci.
USA 91, 12135–12139.spleen cells (0.5 	 106 /ml) were cultured in complete medium alone
or in the presence of LPS (20 g/ml), anti-CD40-IgM (1 g/ml) for Castigli, E., Young, F., Carossino, A.M., Alt, F.W., and Geha, R.S.
72 hr, pulsed with 1 Ci [3 H]-thymidine for an additional 16 hr, then (1996). CD40 expression and function in murine B cell ontogeny.
harvested and scintillation counted. Int. Immunol. 8, 405–411.
Cheng, G., Cleary, A.M., Ye, Z., Hong, D.I., Lederman, S., and Balti-
Surface Expression of CD23, CD54, and CD86 more, D. (1995). Involvement of CRAF1, a relative of TRAF, in CD40
Purified splenic B cells (90% B220) obtained using Dynabeads signaling. Science 267, 1494–1498.
M-280 Streptavidin (Dynal) after incubation with biotinylated anti-
Chu, C.C., Paul, W.E., and Max, E.E. (1992). Quantitation of immuno-body cocktail Thy1.2 (53-2.1), Mac1 (M1/70), and Gr-1 (RB6-8C5)
globulin 1 heavy chain switch region recombination by a diges-(Pharmingen) were cultured overnight with medium, sCD40L (1:20
tion-circularization polymerase chain reaction. Proc. Natl. Acad. Sci.dilution of supernatants from muCD40L:muCD8 transfected J558L
USA 89, 6978–6982.cells), control supernatants (1:20 dilution of J558L cells transfected
Dadgostar, H., Zarnegar, B., Hoffmann, A., Qin, X.F., Truong, U.,with empty plasmid), or LPS (20 g/ml). Cells were then washed and
Rao, G., Baltimore, D., and Cheng, G. (2002). Cooperation of multipledouble stained as described above with anti-CD40-PE and FITC-
signaling pathways in CD40-regulated gene expression in B lympho-conjugated mAbs to either CD23 (B3B4), CD54 (3E2), or CD86 (GL1)
cytes. Proc. Natl. Acad. Sci. USA 99, 1497–1502.or with the appropriate isotype controls, all from Pharmingen. Analy-
sis was performed by gating on CD40 B cells. Doffinger, R., Smahi, A., Bessia, C., Geissmann, F., Feinberg, J.,
Durandy, A., Bodemer, C., Kenwrick, S., Dupuis-Girod, S., Blanche,
S., et al. (2001). X-linked anhidrotic ectodermal dysplasia with immu-EMSA for NFB
nodeficiency is caused by impaired NF-kappaB signaling. Nat.Spleen cells were stained with PE-conjugated rat anti-mouse CD40,
Genet. 27, 277–285.and CD40B cells were sorted using a FACSVantage SE cell sorter
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formed on nuclear extracts (0.8 g/lane) as described (Tsitsikov et pression of the CD40 ligand in X chromosome-linked immunoglobu-
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immunodeficiency virus (HIV) 1 Long terminal repeat TCGCTGGGG USA 90, 2170–2173.
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analysis was performed using unpaired t test with Welch’s cor- secretion, and Ig production following ligation of CD40 on human
rection. B cells. J. Immunol. 161, 1183–1193.
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MAP Kinase Phosphorylation and is critical for CD40 induction of gene expression in b cells.
FACS sorted CD40 splenic B cells were suspended in RPMI-1640 Immunity 6, 379–388.
medium for 2 hr at 37C before stimulation with anti-CD40-IgM (1
Hasbold, J., Lyons, A.B., Kehry, M.R., and Hodgkin, P.D. (1998). Cellg/ml). Activated MAP-kinases were detected by immunoblotting
division number regulates IgG1 and IgE switching of B cells followinglysates from 1.5 	 106 cells with phospho-p38 and phospho-SAPK/
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